Openbookopenbook
Equity
TRUP
+0.0 · +0.00%
USD · NASDAQ

Trupanion Inc(TRUP) Stock Analysis | Financial Services

USD --+0.00%
Reward57Moderate
Risk51Moderate
75%Data
Thin 2% profit margin · Revenue growing 11% YoY
Profitless Growth
Market Cap:1.30Bn
ⓘ
Reward Rating
57
Moderate
Reward Assessment
75% data coverage
Top 50% of stocksView factors
ⓘ
Risk Rating
51
Moderate
Risk Assessment
2 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on TRUP to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for TRUP, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $34.25.

What is Trupanion Inc?

, together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe.

TRUP · Verdict

Solid reward · elevated risk

TRUP stands out on growth and balance sheet, but watch the volatility signal.

Based on 88% data coverage

TRUP · Verdict

What’s working & what to watch

Strengths 2

  • Growth75/100

    Revenue +16.7% CAGR

  • Balance sheet68/100

    Interest covered 2.6×

Watchouts 3

  • Volatility35/100

    Below average

  • Valuation36/100

    P/E 1428.6× · PEG 262.34

  • Profitability44/100

    1% net margin · 6% ROE

Model-based scoring. For information only — not financial advice.

What is Trupanion Inc?

, together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business. The company is listed on the NASDAQ in USA, operating in the Financial Services sector, with a market capitalisation of 1.30B, and a P/E ratio of 57.0x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Profitability metrics are mixed — margins may be under pressure.
Risk
Performance tied to macro conditions — sensitive to interest rate cycles.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (57)

The scoring profile indicates moderate reward potential, with growth and momentum as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Insurance - Property & Casualty names that are close enough in size to make side-by-side comparison useful.

PRASmall Cap / 1.3B market cap
ProAssurance Corporation
Compare
ASICSmall Cap / 1.2B market cap
Ategrity Specialty Insurance Company Holdings
Compare
UFCSSmall Cap / 1.4B market cap
United Fire Group Inc
Compare
Company Information
SectorFinancial Services
IndustryInsurance - Property & Casualty
Market Cap1.30B
P/E Ratio57.0192
Dividend YieldN/A
Beta1.429
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
28,222 shares
$230k
0
6-9months
723,315 shares
$730k
0
9-12months
790,233 shares
$3.8M
0
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.